News

Petrovax sponsors All-Russia Forum ‘Public Immunity-2019’
Petrovax sponsors All-Russia Forum ‘Public Immunity-2019’
Petrovax sponsors All-Russia Forum ‘Public Immunity-2019’
04.12.2019
Petrovax restyles its logo
Petrovax restyles its logo
Petrovax restyles its logo
22.11.2019
An Additional Component Can Triple Vaccine Efficiency, and Scientists Explained How
An Additional Component Can Triple Vaccine Efficiency, and...
An Additional Component Can Triple Vaccine Efficiency, and Scientists Explained How
08.11.2019
National assembly «Protected generation»
National assembly «Protected generation»
National assembly «Protected generation»
24.10.2019
Velson® TV campaign launched
Velson® TV campaign launched
Velson® TV campaign launched
17.10.2019
Petrovax completed Grippol® plus vaccine supplies to Russian and EEU markets on schedule
Petrovax completed Grippol® plus vaccine supplies to...
Petrovax completed Grippol® plus vaccine supplies to Russian and EEU markets on schedule
16.10.2019
Petrovax Day for pharma camp ‘FILIN’ students
Petrovax Day for pharma camp ‘FILIN’ students
Petrovax Day for pharma camp ‘FILIN’ students
03.10.2019
Influenza vaccine Grippol® Quadrivalent approved for children 6 years and over
Influenza vaccine Grippol® Quadrivalent approved for...
Influenza vaccine Grippol® Quadrivalent approved for children 6 years and over
26.09.2019
NPO Petrovax Pharm launches Velson® for sleep normalization and regulation of human biorhythms
NPO Petrovax Pharm launches Velson® for sleep normalization...
NPO Petrovax Pharm launches Velson® for sleep normalization and regulation of human biorhythms
06.08.2019
Follow-up to roundtable “Integration into the world pharmaceutical market. The history of a Russian molecule”
Follow-up to roundtable “Integration into the world...
Follow-up to roundtable “Integration into the world pharmaceutical market. The history of a Russian molecule”
18.07.2019
NPO Petrovax Pharm completes construction of a new manufacturing facility
NPO Petrovax Pharm completes construction of a new...
NPO Petrovax Pharm completes construction of a new manufacturing facility
17.07.2019
Petrovax Pharm once again attested for EU GMP certificate
Petrovax Pharm once again attested for EU GMP certificate
Petrovax Pharm once again attested for EU GMP certificate
11.07.2019
NPO Petrovax Pharm LLC’s office to change location
NPO Petrovax Pharm LLC’s office to change location
NPO Petrovax Pharm LLC’s office to change location
27.06.2019
German companies visit Petrovax Pharm facility
German companies visit Petrovax Pharm facility
German companies visit Petrovax Pharm facility
05.06.2019
Congratulations on the 80th Birthday of Nekrasov Arkady Vasilyevich!
Congratulations on the 80th Birthday of Nekrasov Arkady...
Congratulations on the 80th Birthday of Nekrasov Arkady Vasilyevich!
11.05.2019
In Europe, the results of the latest study on the adjuvant role as an influenza vaccine ingredient were presented
In Europe, the results of the latest study on the adjuvant...
In Europe, the results of the latest study on the adjuvant role as an influenza vaccine ingredient were presented
11.04.2019
NPO Petrovax Pharm is a prizewinner of the Award «Russian Business Guide. People of the year».
NPO Petrovax Pharm is a prizewinner of the Award «Russian...
NPO Petrovax Pharm is a prizewinner of the Award «Russian Business Guide. People of the year».
01.04.2019
Petrovax Pharm continues building up export presence
Petrovax Pharm continues building up export presence
Petrovax Pharm continues building up export presence
14.02.2019
Petrovax Pharm launches inaugural nationwide TV media campaign for Longidaze®
Petrovax Pharm launches inaugural nationwide TV media...
Petrovax Pharm launches inaugural nationwide TV media campaign for Longidaze®
17.01.2019
Russian Health Week: Petrovax Pharm participates in PharmMedProm-2018 Exhibition and Russia’s Immunobiological Shield Congress
Russian Health Week: Petrovax Pharm participates in...
Russian Health Week: Petrovax Pharm participates in PharmMedProm-2018 Exhibition and Russia’s Immunobiological Shield Congress
11.12.2018

About us
Petrovax today
Figures and facts
History
R&D Center
Manufacturing
Quality control
Corporate social responsibility
Сareer
Pharmacovigilance
Contacts
Pharmaceuticals
Polyoxidonium®
Longidaze®
Velson®
Vaccines
Grippol® Plus
Grippol® Quadrivalent
Prevenar® 13
Cosmetic products
Imoferaza®
Partners
Geographic
Partnerships in Russia
International cooperation
Media
News
Scientific articles
Media kit
Media contacts
Site map
Contacts
12 Presnenskaya embankment, Federation Tower East, floor 38 (Moscow City), Moscow 123112, Russia
Tel.: +7 (495) 730-75-45
Fax: +7 (495) 730-75-60
info@petrovax.ru

Social media
© Petrovax
The materials posted on the site are for informational purposes only and are not intended to advertise or promote the manufacturer or medications produced.